Skip to content

Effectiveness of Shenbing Prescription for recovery of gastrointestinal function after gynaecological surgery: a protocol for a randomised controlled trial

A Prospective?Randomized and Controlled Clinical Study for the Effect of Shenbing Prescription on Gastrointestinal Function after Gynecological Abdominal Surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022380
Enrollment
Unknown
Registered
2019-04-09
Start date
2019-05-05
Completion date
Unknown
Last updated
2020-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological patients after abdominal surgery

Interventions

Sponsors

Guangdong Provincial Hospital of Chinese Mediciine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Patients after gynecological laparoscopy and laparotomy. 2) 40 -70 years old. 3) The operation time is 1-4 hours. 4) anesthesia time 1.5-4.5 hours. 5) Traditional Chinese medicine syndrome is characterized by qi deficiency and qi stagnation, and obstruction of fu-organs and qi. 6) Those who have signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Malignant tumor requires extended radical surgery/enterostomy or advanced malignant fluid and extreme debility. 2) Patients with heart, liver, kidney, brain, diabetes, hypertension and other complicated diseases that cannot be controlled after treatment and have obvious symptoms. 3) Persons with mental diseases, allergy to therapeutic drugs, pregnant women or breast-feeding. 4) serum albumin < 27g/l in patients with moderate or above malnutrition; Or prealbumin < 0.14g/l. 5) Severe intestinal adhesion after another abdominal operation. 6) If the intraoperative blood loss exceeds 400ml, or if blood transfusion is needed. 7) Severe Complication (medicine) occurred within 6 hours after operation. 8) Postoperative intraperitoneal thermal perfusion is required. 9) Drugs or therapies that have obvious effects on gastrointestinal function must be used after operation. 10) Patients currently participating in or having participated in other clinical trials within 1 month before this study. 11) Researchers think it is inappropriate to conduct this clinical research.

Design outcomes

Primary

MeasureTime frame
Brain gut peptide hormone 3 items;Time of first anal exhaust and defecation after operation;

Secondary

MeasureTime frame
Metabolomics;

Countries

China

Contacts

Public ContactXuefang Liang

Guangdong Provincial Hospital of Chinese Mediciine

liangxuefang2006@126.com+86 13926082916

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026